Top Markets
#1 Asteroid Shiba Asteroid Shiba +107,904.87%
#2 Moonriver Moonriver +162.76%
#3 inSure DeFi inSure DeFi +124.65%
#4 Lorenzo stBTC Lorenzo stBTC +78.86%
#5 Metis Metis +60.18%
#6 SOON SOON +44.13%
#7 tomiNet tomiNet +41.49%
#8 Sapien Sapien +34.55%
#9 Audius Audius +32.07%
#10 ZetaChain ZetaChain +20.94%
Coin of the day
Asteroid Shiba Asteroid Shiba
Settings
Language
ENGLISH
Currency
USD
Theme
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Rank in Stocks #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Share Price
$9.13
Market Cap
$39.27K
Change (1 day)
0.00%
Change (1 year)
-11.76%
Country
IE
Trade Malin Corporation plc (MLC)

Category

Healthcare
Revenue for Malin Corporation plc (MLC)
Revenue in Dec 2025 TTM: 0.00
According to Malin Corporation plc latest financial reports the company's current revenue (TTM) is 0.00. In 2023 the company made a revenue of 0.00 equal to the revenue in the year 2022 that was 0.00. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Malin Corporation plc from 2015 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 -100.00%
2020 $49.93M 27.52%
2019 $39.16M -10.33%
2018 $43.67M -13.14%
2017 $50.28M 13.50%
2016 $44.30M 78.15%
2015 $24.87M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 $4.43B -
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 $24.76B -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 $28.60B -
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
 $9.47B -
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.31B -
IN